R. Reynolds

发表

A. Bate, J. Hallas, G. Requena, 2009, 2009 Device Research Conference.

Cigarette smoking and erectile dysfunction among Chinese men without clinical vascular disease.

K. Reynolds, P. Whelton, Xi-gui Wu, 2007, American journal of epidemiology.

Inpatient drug utilization in Europe: nationwide data sources and a review of publications on a selected group of medicines (PROTECT project).

R. Reynolds, O. Klungel, L. Ibañez, 2015, Basic & clinical pharmacology & toxicology.

Impact of methodological choices on findings from pharmacoepidemiological studies: Final results of the IMI-protect (pharmacoepidemiological research on outcomes of therapeutics by a European consortium) project

H. Gardarsdottir, R. Reynolds, C. Gasse, 2014 .

The risk of acute liver injury among users of antibiotic medications: a comparison of case‐only studies.

L. Smeeth, R. Reynolds, I. Douglas, 2015, Pharmacoepidemiology and drug safety.

Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications

A. Egberts, G. Requena, H. Gardarsdottir, 2014, European Journal of Clinical Pharmacology.

Do case‐only designs yield consistent results across design and different databases? A case study of hip fractures and benzodiazepines†

A. Bate, G. Requena, J. Logie, 2015, Pharmacoepidemiology and drug safety.

Prevalence of antibiotic use: a comparison across various European health care data sources

L. Smeeth, A. Bate, G. Requena, 2015, Pharmacoepidemiology and drug safety.

Seasonal changes in prescribing of long-acting beta-2-agonists-containing drugs.

J. Hasford, G. Requena, C. Huerta, 2015, Respiratory medicine.

Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD)

R. Reynolds, M. D. De Bruin, M. D. de Groot, 2016, BMJ Open.

Utilisation and Off-Label Prescriptions of Respiratory Drugs in Children

J. Hasford, R. Reynolds, R. Fischer, 2014, PloS one.

P he Frequency and Incremental Cost of Major omplications Among Medicare Beneficiaries eceiving Implantable Cardioverter-Defibrillators

R. Reynolds, D. Cohen, E. Becker, 2006 .

Risk of acute liver injury associated with use of antibiotics. Comparative cohort and nested case–control studies using two primary care databases in Europe

L. Smeeth, A. Bate, C. Huerta, 2016, Pharmacoepidemiology and drug safety.

Ascertainment of acute liver injury in two European primary care databases

A. Bate, G. Requena, C. Huerta, 2014, European Journal of Clinical Pharmacology.

Cost-Minimization Analysis of Piperacillin/Tazobactam versus Imipenem/Cilastatin for the Treatment of Serious Infections: A Canadian Hospital Perspective

R. Reynolds, E. Bryce, C. Marra, 1999, The Annals of pharmacotherapy.

Piperacillin/tazobactam versus imipenem: a double-blind, randomized formulary feasibility study at a major teaching hospital.

R. Reynolds, E. Bryce, F. Marra, 1998, Diagnostic microbiology and infectious disease.

Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT‐EU project

A. Bate, G. Requena, J. Logie, 2016, Pharmacoepidemiology and drug safety.

Impact of varying outcomes and definitions of suicidality on the associations of antiepileptic drugs and suicidality: comparisons from UK Clinical Practice Research Datalink (CPRD) and Danish national registries (DNR)

Y. Alvarez, R. Reynolds, R. Schlienger, 2016, Pharmacoepidemiology and drug safety.

A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

J. Hasford, P. Souverein, R. Reynolds, 2016, European Journal of Clinical Pharmacology.

Prescribing of long-acting beta-2-agonists/inhaled corticosteroids after the SMART trial

J. Hasford, R. Reynolds, R. Fischer, 2015, BMC Pulmonary Medicine.

Chlamydia trachomatis in Adolescents and Adults

R. Reynolds, C. Marra, F. Marra, 1998, PharmacoEconomics.

Chlamydia trachomatis in adolescents and adults. Clinical and economic implications.

R. Reynolds, C. Marra, F. Marra, 1998, PharmacoEconomics.

Incidence Rates and Trends of Hip/Femur Fractures in Five European Countries: Comparison Using E-Healthcare Records Databases

A. Bate, G. Requena, H. Gardarsdottir, 2014, Calcified Tissue International.

Understanding inconsistency in the results from observational pharmacoepidemiological studies: the case of antidepressant use and risk of hip/femur fractures

G. Requena, J. Logie, H. Gardarsdottir, 2016, Pharmacoepidemiology and drug safety.

Antiepileptic drugs and risk of suicide attempts: a case–control study exploring the impact of underlying medical conditions

R. Reynolds, L. Abenhaim, M. Rossignol, 2017, Pharmacoepidemiology and drug safety.

Case‐only designs for studying the association of antidepressants and hip or femur fracture

A. Hoes, H. Gardarsdottir, P. Souverein, 2016, Pharmacoepidemiology and drug safety.

Tiotropium Respimat(®) vs. HandiHaler(®): real-life usage and TIOSPIR trial generalizability.

J. Hasford, R. Reynolds, R. Fischer, 2016, British journal of clinical pharmacology.

Y. Alvarez, R. Reynolds, R. Schlienger, 2016, Pharmacoepidemiology and drug safety.

Abstracts

G. Requena, H. Gardarsdottir, P. Souverein, 2000, Blood Purification.